Cancer Crosslinks 2015
Novel Insights into Tumor Heterogeneity and Clonal Evolution: How to Design Treatment and Follow-up Strategies?
Event 2015 - Speakers & Topics
Paul Baas, Professor, Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands
- Treatment strategies 2015: How to Combine Molecularly Targeted Therapies and Emerging Cancer Immunotherapies Based on Molecular Insights into the Tumor?
Nicholas Navin, Professor, The University of Texas MD Anderson Cancer Center, Houston, USA
- Investigating Clonal Diversity and Evolution in Breast Cancer with Single Cell Genomics
Randy F. Sweis, Assistant Professor, Section of Hematology/Oncology, Committee on Clinical Pharmacology and Pharmacogenomics The University of Chicago Medicine & Biological Sciences, USA
- Immunophenotypes: The T cell-inflamed Tumor Microenvironment as a Biomarker and its Clinical Implications
Kimmo Porkka, Professor, Hematology Research Unit, University of Helsinki, Finland
- Hematology Focus: Better Treatment Decisions via Combining Molecular Characterization and Functional Screening? Which Experience do We Have? How do We Adapt Future Protocols?
Klaus Pantel, Professor, University Hospital Hamburg-Eppendorf, Germany
- Keynote Presentation: Liquid Biopsies – Monitoring Solid Cancers in the Blood: Where are We Today and How can These Technologies Affect Clinical Decision-making?
Sonia Melo, Professor, IPATIMUP, Porto, Portugal
- Exosomes in Early Detection of Pancreatic Cancer
Q&A Liquid biopsies
Norwegian and International Collaborative Projects: Novel Insights and Their Clinical Implementation – Perspectives and Learnings from Different Indications
Manuel Teixeira, Portuguese Oncology Institute, Porto, Portugal
Norwegian and International Collaborative Projects: Novel Insights and Their Clinical Implementation – Perspectives and Learnings from Different Indications
Manuel Teixeira, Portuguese Oncology Institute, Porto, Portugal
- Clonal Heterogeneity in Epithelial Malignancies: Challenges and Clinical Applications
- Targets for Therapy in Gynecologic Cancers: Does Overlap in Molecular and Histologic Subtypes Support New Strategies for Clinical Trials?
- From Targets to Bullets in Lymphoid Malignancies - Examples from Oslo University Hospital
Panel Discussion with Norwegian and International Speakers -
Defining Treatment Strategies in 2015: Opportunities and Challenges
Defining Treatment Strategies in 2015: Opportunities and Challenges
A complete program for Cancer Crosslinks 2015 may be downloaded HERE.
Event 2015 - Sponsors
|
|
|